Bloomberg -- Bristol-Myers Squibb Co. and Sanofi- Aventis SA won a U.S. Supreme Court fight over their $9.5 billion-a-year Plavix blood thinner as the justices refused to question a patent that bars generic versions until November 2011.
Bloomberg -- Bristol-Myers Squibb Co. and Sanofi- Aventis SA won a U.S. Supreme Court fight over their $9.5 billion-a-year Plavix blood thinner as the justices refused to question a patent that bars generic versions until November 2011.
